ABBVIE INC. vs. NewAmsterdam Pharma Company N.V. Ordinary Shares
ABBV
ABBVIE INC.
$264.34 -0.29%
VS NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares
$22.58 -0.70%
ABBVIE INC. (ABBV) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ABBV | NAMS | |
|---|---|---|
| Market Cap | $467.12 billion | $2.70 billion |
| Revenue (TTM) | $64.39 billion | $7.12 million |
| Net Income (TTM) | $6.32 billion | $-259,504,000 |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | NAMS | |
|---|---|---|
| P/E Ratio | 74.67 | — |
| Price / Book | -79.33 | 4.27 |
| Price / Sales | 7.25 | 379.04 |
ABBV leads on 2 of 2 valuation factors.
Profitability
| ABBV | NAMS | |
|---|---|---|
| Net Margin | 9.81% | -3644.21% |
| Return on Equity | -107.29% | -41.10% |
ABBV and NAMS split the profitability factors evenly.
Dividend
| ABBV | NAMS | |
|---|---|---|
| Dividend Yield | 2.62% | — |
| Payout Ratio | 195.48 | — |
ABBV and NAMS split the dividend factors evenly.
Risk & Sentiment
| ABBV | NAMS | |
|---|---|---|
| Short Interest | 0.85% | 0.01% |
NAMS leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, NAMS overview, NAMS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.